(Q62034128)
Statements
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (English)
0 references
28 February 2019
0 references
1 September 2024
0 references
105
0 references
18 year
0 references